TRT and Alzheimer's Risk: What the Evidence Actually Shows

By Dr. Farhan Abdullah, DO | Medical Director, Magnolia Functional Wellness | Southlake, TX

A patient sat across from me last month, mid-fifties, sharp as a tack, and asked a question I hear more and more these days. His father had Alzheimer's. His grandfather, too. He'd read somewhere that low testosterone might be part of the picture, and he wanted to know: if he started testosterone therapy, would it protect his brain? Could it lower his odds of ending up like the men before him?

It's a fair question, and an important one. It's also one where the honest answer is more complicated than either the supplement marketers or the skeptics will tell you. So let's actually work through it. At Magnolia Functional Wellness here in Southlake, a good part of my job is separating what the research supports from what people wish it supported, and testosterone and the aging brain is a topic where that line matters a great deal.

Low Testosterone and Dementia Risk Are Linked. That's Real.

Let's start with what the data does show, because it's genuinely interesting. Across a large body of observational research, men with lower testosterone levels tend to have higher rates of cognitive decline and dementia, including Alzheimer's disease. This isn't a fringe finding. It shows up repeatedly.

A 2021 systematic review and meta-analysis by Zhang and colleagues in the Journal of Geriatric Psychiatry and Neurology pooled 27 studies covering more than 18,000 participants. Their analysis found that as total testosterone dropped, the risk of all-cause dementia rose, with a hazard ratio of about 1.14. Several of the included studies also linked lower free and bioavailable testosterone to a higher risk of Alzheimer's specifically. So the association between low T and a struggling brain is not something I'm inventing to sell a therapy. It's in the literature.

Now, here's where I have to put on my internal medicine hat and slow things down. An association is not the same as causation, and this distinction is the whole ballgame. When two things travel together, there are usually three possibilities worth considering. Low testosterone could be causing cognitive decline. Cognitive decline, or the poor health that accompanies it, could be dragging testosterone down. Or some third factor, think obesity, diabetes, chronic inflammation, poor sleep, could be quietly driving both at once.

That third scenario is not a technicality. Metabolic dysfunction lowers testosterone and damages the brain independently. A man with untreated type 2 diabetes and sleep apnea is going to have lower T and higher dementia risk, and treating only his hormones while ignoring the rest would be missing the forest for a single tree. In my practice, I've seen far too many men handed a testosterone prescription as if it were the answer to everything, when the real work was elsewhere.

Does Giving Testosterone Actually Protect the Brain?

This is the question that matters most, and it's where the story gets humbling. Because if low testosterone caused Alzheimer's, then raising testosterone should help prevent or slow it. That's a testable idea. Researchers have tested it. And the results have been, to put it plainly, underwhelming.

The cleanest evidence comes from the TEAAM trial, published by Huang and colleagues in The Lancet Diabetes and Endocrinology in 2016. This was a real randomized, double-blind, placebo-controlled study. Men aged 60 and older with low or low-to-normal testosterone were given either testosterone gel or placebo daily for three full years, and their cognition was tracked across multiple domains: memory, verbal fluency, visuospatial ability, attention, executive function. After 36 months, the researchers found no meaningful difference between the testosterone group and the placebo group on any of those measures. None. Their conclusion was blunt: testosterone administration did not improve cognitive function.

What about men who already have Alzheimer's? A smaller randomized trial by Lu and colleagues in Archives of Neurology looked at exactly that. Over 24 weeks, men with mild Alzheimer's received testosterone gel or placebo. The testosterone group reported a real improvement in quality of life, which is not nothing for patients and their families. But on the cognitive tests, the effect was minimal. There was a numerical hint of less decline in some visuospatial tasks, but nothing that would let me sit across from a patient and promise his memory would hold.

So put those together. We have a consistent association between low testosterone and dementia risk, and we have randomized trials showing that giving testosterone doesn't reliably rescue cognition. That combination is exactly the fingerprint you'd expect if testosterone were more of a marker of brain health than a driver of it. The low number is telling you something is wrong. Fixing the number doesn't automatically fix the underlying problem.

Why the Biology Made Everyone Hopeful in the First Place

I don't want to leave the impression that the testosterone-brain hypothesis was silly. It wasn't. There are real mechanistic reasons researchers got excited, and they're worth understanding.

Testosterone and its downstream products act directly on the brain. There are androgen receptors scattered throughout regions critical for memory, including the hippocampus. In laboratory and animal work, testosterone appears to support the survival of neurons, reduce the buildup of beta-amyloid (the sticky protein that clumps into the plaques seen in Alzheimer's), and dampen certain inflammatory processes in brain tissue. On paper, that's a compelling case. A hormone that feeds neurons, clears toxic protein, and calms inflammation sounds like it ought to protect against a disease defined by dying neurons, accumulating protein, and inflammation.

But the brain is not a petri dish, and a fifty-something man with two decades of vascular wear, insulin resistance, and fragmented sleep is not a cultured neuron. This is the recurring lesson of translational medicine. Mechanisms that look perfect in a controlled system often fail to move the needle in a whole, complicated human being. It's not that the biology is fake. It's that biology alone doesn't get a vote once you're dealing with the full messiness of an aging body. The 2023 review of androgens and neurodegeneration makes this same point: the preclinical promise has consistently outrun the clinical results.

What a Real Brain-Health Workup Looks Like

When a man walks in worried about his memory and his family history, the worst thing I could do is pull one lever and call it a day. Testosterone is a single data point. Protecting a brain is a systems problem, and the workup has to reflect that.

So we start wide. Yes, I check a proper morning total and free testosterone, along with the pituitary hormones that tell me whether a low reading is coming from the testicles or from higher up the chain. But that's maybe a fifth of the picture. I want a full metabolic panel, fasting glucose and insulin, hemoglobin A1c, and a lipid profile, because insulin resistance is one of the most under-appreciated threats to the aging brain. Some researchers half-jokingly call Alzheimer's "type 3 diabetes" for a reason. I want inflammatory markers. I want thyroid function, vitamin D, and B12, since deficiencies there can masquerade as cognitive decline and are trivial to correct once you find them.

Then we talk about the things labs don't capture. How are you sleeping? Have you ever been screened for sleep apnea, which shreds both memory and testosterone and hides in plain sight? What does your week of movement actually look like, not the version you'd tell your cardiologist? How much alcohol, honestly? What's your stress load doing to your cortisol? For men with a strong family history, we may also discuss genetic risk factors like ApoE status, though I'm careful there, because knowing your genotype only helps if you're ready to act on it and not just marinate in anxiety over a number you can't change.

The point of all this isn't to bury a patient in tests. It's that the levers which genuinely move dementia risk, blood sugar, sleep, fitness, vascular health, are mostly not the testosterone lever. When I do decide testosterone therapy makes sense, it's because a man is truly low and symptomatic, and it sits inside that larger plan rather than standing in for it. That sequencing matters more than any single prescription.

So What Do I Actually Tell Patients?

Here's where I land, and it's a position I hold with some conviction. Testosterone replacement therapy is a legitimate, valuable treatment for men with genuine, symptomatic hypogonadism, meaning clinically low testosterone confirmed on proper morning lab testing, paired with real symptoms like persistent fatigue, low libido, loss of muscle, depressed mood, and brain fog. For those men, appropriate TRT can restore energy, mood, body composition, and quality of life. That's well established, and it's a big part of what we do at our testosterone replacement therapy program.

What I will not do is prescribe testosterone as an Alzheimer's prevention strategy, because the evidence does not support that claim. If a man comes to me terrified of dementia and hoping a hormone will be his shield, I owe him the truth: there is no randomized trial showing testosterone prevents or slows Alzheimer's, and the best long-term data we have showed no cognitive benefit at all. Selling him TRT on a promise it can't keep would be a disservice, and frankly, it's the kind of overreach that gives functional medicine a bad name.

But that conversation doesn't end in despair, because here's the part that actually helps. The things that genuinely protect the aging brain are the same things that support healthy testosterone in the first place. Regular resistance and aerobic exercise. Real sleep, seven to nine hours, with sleep apnea diagnosed and treated if it's there. Tight control of blood sugar and blood pressure. Managing visceral fat. Staying socially and mentally engaged. These aren't consolation prizes. They are the actual intervention, and they move testosterone and cognition in the same direction because they address the shared roots underneath both. This is exactly the terrain we work in through longevity medicine, where the goal is protecting healthspan, not chasing a single number.

If you've got a family history of Alzheimer's, you're right to take it seriously, and you're right to be looking for levers you can pull. Testosterone might be one piece of your health picture, especially if you're genuinely low and symptomatic. It is not a magic shield for your brain, and any clinic telling you otherwise is getting ahead of the science. The smarter move is a thorough workup, honest labs, and a plan that treats the whole person. That's the kind of medicine we practice at Magnolia Functional Wellness in Southlake, and it always starts the same way: with your real story and your real numbers, not a shortcut. If your brain is what you're worried about, let's build a plan that actually earns that worry.